Wayne W. Petko

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

Gina M. Bores, Francis P. Huger, Wayne W. Petko et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 247 citations

Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex

Garth E. Ringheim, Ann Marie Szczepanik, Wayne W. Petko et al. · Molecular Brain Research · 1998 · 125 citations

Inflammation, Cytokine, Autoimmune Disease +7

Synthesis and Structure−Activity Relationships of <i>N</i>-Propyl-<i>N</i>-(4-pyridinyl)-1<i>H</i>-indol-1-amine (Besipirdine) and Related Analogs as Potential Therapeutic Agents for Alzheimer's Disease

Joseph Klein, Larry J. Davis, Gordon E. Olsen et al. · Journal of Medicinal Chemistry · 1996 · 62 citations · Full text

Imino 1,2,3,4-tetrahydrocyclopent[b]indole carbamates as dual inhibitors of acetylcholinesterase and monoamine oxidase

David M. Fink, M.G. Palermo, Gina M. Bores et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 37 citations

Medicinal Chemistry, Biochemistry, Dual Inhibitors +7

Pharmacological Activity and Safety Profile of P10358, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease

Craig P. Smith, Gina M. Bores, Wayne W. Petko et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 35 citations